Juluca approved in Canada for HIV treatment

[From CATIE, May 29, 2018] In May 2018, Health Canada approved the use and sale of a fixed-dose combination of two medicines—dolutegravir + rilpivirine—sold under the brand name Juluca as maintenance therapy for HIV.

For more, click here.